In addition, loss of ERα expression and CAFs is linked to a poor response of BC cells to TAM, with the suppression of the activity of CD63+ CAFs to enhance TAM sensitivity in BC cells, in vivo (Gao et al., 2020). This evidence concerns the gene CD63 and breast cancer.